z-logo
open-access-imgOpen Access
Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
Author(s) -
Sara Sadeghi,
Azadeh Goodarzi
Publication year - 2022
Publication title -
dermatology practical and conceptual
Language(s) - English
Resource type - Journals
ISSN - 2160-9381
DOI - 10.5826/dpc.1204a178
Subject(s) - tofacitinib , ruxolitinib , medicine , janus kinase , janus kinase inhibitor , vitiligo , psoriasis , rheumatoid arthritis , abatacept , alopecia areata , psoriatic arthritis , immunology , rheumatology , dermatology , rituximab , cytokine , bone marrow , lymphoma , myelofibrosis

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom